About this trial
In our thesis, we will compare the effectiveness of low-intensity shock wave versus acetylcholine iontophoresis as a possible new therapy for microcirculation changes in type 2 diabetic neuropathy
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients have to be symptomatically stable with type 2 diabetes mellitus complicated with peripheral neuropathy.
Optimized pharmacological treatment that will be remained unchanged throughout the study.
Disqualifiers
Implanted cardiac pacemakers.
Patients with known skin allergies.
Presence of skin inflammations.
Peripheral vascular disease.
Trial design
Parallel
Treatments tested in this trial
Low-intensity extracorporeal shock wave
DeviceAcetylcholine iontophoresis• The Iontophoresis comprises of electric impulses from a low voltage galvanic current stimulation unit to drive ions (Ach) (1%) into soft tissue structures.
Treatment groups
Trial outcomes
Primary outcomes
Electrophysiological investigations of peripheral nerves (latency, amplitude and velocity of peripheral nerves)
Electrophysiological investigations of peripheral nerves were measured pre and post treatment for both groups (latency, amplitude and velocity of peripheral nerves)
Secondary outcomes
Nitric oxide laboratories for measurement of nitric oxide level
Nitric oxide laboratories for measurement of nitric oxide level were measured pre and post treatment for both groups.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: